Enhancing member engagement in a Tier 3 personality disorder service during COVID-19: evaluation of a virtual group programme.
Behav Cogn Psychother
; 50(6): 629-643, 2022 Nov.
Article
in English
| MEDLINE | ID: covidwho-2016484
ABSTRACT
BACKGROUND:
Drop-out rates from evidence-based interventions for people with a diagnosis of personality disorder (PD) are high. The COVID-19 pandemic has likely exacerbated barriers to engagement with the introduction of virtual working. Virtual therapy has a good evidence-base for Axis I disorders, but limited research for Axis II disorders.AIMS:
To investigate facilitators and barriers to engagement in a Tier 3 PD service virtual group programme.METHOD:
A virtual group programme was developed in collaboration with service members, and analysed members' attendance rates over a 5-month period pre- and post-COVID-19. Thematic analysis of semi-structured telephone interviews with 38 members is reported, describing their experience of the virtual group programme.RESULTS:
Attendance rates were significantly higher pre-COVID (72%) than post-COVID (50%). Thematic analysis highlighted key barriers to attendance were practical issues, low motivation, challenges of working in a group online and feeling triggered at home. Main promoters of engagement were feeling valued, continued sense of connection and maintaining focus on recovery.DISCUSSION:
The results suggest that the pandemic has exacerbated relational and practical barriers to engagement in a Tier 3 PD service. Ways of enhancing engagement are discussed, as well as preliminary recommendation for services offering virtual therapy to people with a diagnosis of PD.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
Type of study:
Experimental Studies
/
Qualitative research
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Behav Cogn Psychother
Journal subject:
Behavioral Sciences
/
Psychiatry
Year:
2022
Document Type:
Article
Affiliation country:
S1352465822000339
Similar
MEDLINE
...
LILACS
LIS